Company Filing History:
Years Active: 2012
Title: Susanne Kolar: Innovator in Pharmaceutical Chemistry
Introduction
Susanne Kolar is a notable inventor based in Neufeld/Leitha, Austria. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the production of high-purity compounds. Her work is characterized by innovative methods that enhance the quality and efficacy of pharmaceutical raw materials.
Latest Patents
Susanne Kolar holds a patent for a method titled "Method for the production of high-purity 4a, 5, 9, 10, 11, 12,-hexahydro-6H-benzofuro [3a, 3, 2-ef] [2] benzazepine, and the derivatives thereof." This process provides a way to produce extremely pure galanthamine and its derivatives. The method involves debrominating racemic bromine narwedine under palladium catalysis, followed by a reaction that converts the palladium catalyst into an easily separable form. The process culminates in the production of enantiomerically pure galanthamine, which can be used directly as a pharmaceutical raw material.
Career Highlights
Susanne Kolar is associated with Sanochemia Pharmazeutika AG, where she applies her expertise in pharmaceutical development. Her innovative approach has led to advancements in the production of high-purity compounds, which are crucial for the pharmaceutical industry.
Collaborations
Throughout her career, Susanne has collaborated with esteemed colleagues such as Stefan Welzig and Anton Gerdenitsch. These partnerships have fostered a collaborative environment that enhances research and development efforts in her field.
Conclusion
Susanne Kolar's contributions to pharmaceutical chemistry exemplify the impact of innovative thinking in the development of high-purity compounds. Her work not only advances scientific knowledge but also plays a vital role in the pharmaceutical industry.